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Abstract
Background: Annual prevalence of gestational diabetes mellitus (GDM) is 12.5% among Finnish pregnant women.
The prevalence is expected to rise with the increasing overweight among women before pregnancy. Physical
activity and diet are both known to have favourable effects on insulin resistance and possibly on the risk of GDM.
We aimed to investigate, whether GDM can be prevented by counseling on diet, physical activity and gestational
weight gain during pregnancy.
Methods/Design: A cluster-randomized controlled trial was conducted in 14 municipalities in the southern part of
Finland. Pairwise randomization was performed in order to take into account socioeconomic differences. Recruited
women were at 8-12 weeks' gestation and fulfilled at least one of the following criteria: body mass index ≥ 25 kg/
m
2, history of earlier gestational glucose intolerance or macrosomic newborn (> 4500 g), age ≥ 40 years, first or
second degree relative with history of type 1 or 2 diabetes. Main exclusion criterion was pathological oral glucose
tolerance test (OGTT) at 8-12 weeks' gestation. The trial included one counseling session on physical activity at 8-
12 weeks' gestation and one for diet at 16-18 weeks' gestation, and three to four booster sessions during other
routine visits. In the control clinics women received usual care. Information on height, weight gain and other
gestational factors was obtained from maternity cards. Physical activity, dietary intake and quality of life were
followed by questionnaires during pregnancy and at 1-year postpartum. Blood samples for lipid status, hormones,
insulin and OGTT were taken at 8-12 and 26-28 weeks' gestation and 1 year postpartum. Workability and return to
work were elicited by a questionnaire at 1- year postpartum. Linkage to the national birth register of years 2007-
2009 will provide information on perinatal complications and GDM incidence among the non-participants of the
study. Cost-effectiveness evaluation will be based on quality-adjusted life years. This study has received ethical
approval from the Ethical board of Pirkanmaa Hospital District.
Discussion: The study will provide information on the effectiveness and cost-effectiveness of gestational physical
activity and dietary counseling on prevention of GDM in a risk group of women. Also information on the
prevalence of GDM and postpartum metabolic syndrome will be gained. Results on maintaining the possible
health behaviour changes are important in order to prevent chronic diseases such as cardiovascular disease and
diabetes.
Trial registration: The trial is registered ISRCTN 33885819
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Gestational diabetes mellitus (GDM) is defined as a type
of diabetes firstly diagnosed during pregnancy [1,2].
Insulin sensitivity usually decreases towards the end of
pregnancy and is therefore partly physiological, but
among part of pregnant women it results to glucose
intolerance and GDM [3]. Prevalence estimates vary,
usually approximately 5% ofp r e g n a n tw o m e nd e v e l o p
GDM [4]. In Finland the average prevalence of GDM is
12.5%, but varies from 6 to 25% between different hospi-
tal districts, at least partly due to different diagnostic
criteria [5].
Although glucose metabolism usually normalises after
delivery, majority of women with GDM have an
increased risk of later diabetes mellitus or impaired glu-
cose tolerance and possibly also of metabolic syndrome
[6-9]. In a Danish sample (N = 481), the prevalence of
metabolic syndrome approximately 10 years after preg-
nancy was three times as high in women with prior
diet-treated GDM as in 1000 age-matched population-
based control subjects [10]. Although the prevalence of
metabolic syndrome after one year is lower than ten
years after delivery, women with GDM risk have been
reported as forerunners of maternal and childhood obe-
sity [8]. GDM and overall obesity among women reflects
also to children's weight development. Women with
G D Mh a v em o r eo f t e nm a c r o s o m i cn e w b o r n s( b i r t h
weight ≥ 4000 g) and the related health problems than
other women [11]. Intrauterine hyperglycaemia may
contribute to the pathogenesis of offspring overweight
and metabolic syndrome later in life [12].
The most important risk factors of GDM are high
maternal age, family history of type 2 diabetes and over-
weight before pregnancy [13] and GDM or glucose
intolerance in previous pregnancies [7]. There is also
some evidence that excessive gestational weight gain,
high intake of saturated fat and low intake of polyunsa-
turated fat may increase the risk of GDM [4,14-17]. On
the other hand, physical activity improves glucose toler-
ance and insulin sensitivity in pregnant women [18].
Physical activity before or during pregnancy is also asso-
ciated with reduced risk of GDM [19-21]. In the case-
control study by Dempsey et al. [22] women, who were
engaged in physical activity had almost 50% reduction
in risk of GDM compared with inactive women.
Lifestyle modifications have been shown valuable
adjunctive therapy in the treatment of GDM [23]. More-
over, there is encouraging evidence on the impact of
lifestyle interventions to prevent the progression of
GDM to type 2 diabetes in women with history of GDM
[24]. The small trials by Mottola et al. [25] and Hui et al
[26] showed promising results in preventing GDM with
nutrition and physical activity modification. In our own
pilot study (n = 105), pregnant women who had intensi-
fied dietary and physical activity counseling at routine
maternity clinic visits were able to change their diet to
favourable direction and to maintain at least moderate
physical activity more often than the women with rou-
tine counseling [27,28]. Interestingly, there were no high
birth weight newborns in the intervention group, but
eight of them (15%) in the control group, suggesting
that the intervention may have had beneficial effect on
maternal glucose tolerance.
The evidence for the effect of lifestyle modification in
preventing GDM will accumulate in the future from
ongoing studies by Chasan-Taber et al [29] and Oost-
dam et al [30] and from our study presented here. The
primary objective of our trial is to show whether indivi-
dual counseling on physical activity, diet and gestational
weight gain can have preventive effect on the develop-
ment of GDM. Secondary objectives of our trial are to
evaluate maternal and child weight development, mater-
nal metabolic changes, and changes in maternal physical
activity and dietary habits and quality of life. Cost-effec-
tiveness of the trial is evaluated since the prevention of
GDM is important in order to reduce direct health care
costs, such as hospital days and surgical procedures and
indirect costs due to sick leave during pregnancy. To
date no cost-effectiveness studies have been published
on the prevention of GDM. The purpose of this paper is
to describe the design and the methods of a cluster-ran-
domized controlled trial (RCT) to prevent GDM and its
1-year follow-up.
Methods/Design
Study design, setting and group allocation
The RCT was conducted in primary health care mater-
nity clinics in Pirkanmaa region, situated south-western
part of Finland (Figure 1). The prevalence of GDM was
17% in Pirkanmaa region in 2004[5]. Municipalities in
Pirkanmaa region with at least 70 annual deliveries were
contacted and recruited to the study (N = 14). The city
of Tampere, with more than 200.000 inhabitants and 23
maternity clinics, was the biggest of these municipalities.
However, it was the only municipality restricting the
number of participating maternity clinics to one due to
the extra workload accumulated to the nurses from the
study arrangements and counseling. All clinics from the
other municipalities took part in the study.
For the cluster randomisation, the municipalities were
arranged into matched pairs and within each pair they
were randomized to an trial and a control municipality.
The pair-matching was done with regard to number of
births, size and socio-economic level of the population,
estimated incidence of GDM and whether the clinic
situated in rural or urban area. Municipalities were
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pregnant women to avoid contamination.
In Finland, maternity health care is provided by the
municipalities and funded through public taxation. The
visits are free of charge for women. Almost all pregnant
women (99.7%) utilize municipal maternity care services,
although there are private services available as well
[5,31]. Currently, first-time pregnant women are recom-
mended to visit a nurse 11-15 times and a physician
three times during pregnancy [31,32]. The recom-
mended number of visits is lower (7-11) during subse-
quent pregnancies. The first visit to maternity clinics
usually takes place when women are at approximately 8
to 12 weeks' gestation. The spouses are encouraged to
attend all visits.
Recruitment of study population
In total, 23 nurses from the trial clinics and 30 nurses
from the control clinics participated in the implementa-
tion of the study. The nurses recruited pregnant women
when they contacted the maternity clinic for the first
time by telephone (up to 12 weeks' gestation). The
women who were interested in participating in trial
received an invitation letter and the informed consent
form by mail. The eligible women willing to participate
signed the informed consent during the first maternity
visit. If the women were not eligible or not willing to
participate, they were asked to complete a baseline ques-
tionnaire and another informed consent for later linkage
to the birth registry information.
The nurses used structured form to keep record on
the women invited and eligible to the study and of those
eligible or not wanting to participate. The form also
included space for entering the reasons for dropping
out. Recruitment was planned to continue until at least
30 women were enrolled in each municipality. All parti-
cipants of the trial including the non-participants who
were willing to fill the baseline questionnaire, were
included in the follow-up study. Ethical approval for this
study was obtained from the Ethical board of Pirkanmaa
Hospital District (Reference number R06230, 19.1.2007).
Inclusion and exclusion criteria
Inclusion criteria
Pregnant women were eligible for the study if they had
at least one of the following risk factors: BMI ≥ 25 kg/
m
2, GDM or any signs of glucose intolerance or macro-
somic newborn (≥ 4500 g) in any earlier pregnancy, type
1 or 2 diabetes in first or second grade relatives or age
≥ 40 years.
Exclusion criteria
Women were excluded if they had at least one of the
following: a pathological value in the baseline oral glu-
cose tolerance test (OGTT) at 8-12 weeks' gestation
(blood glucose > 5.3 mmol/l at fasting, > 10.0 mmol/l at
1-hour or >8.6 mmol/l at 2-hour), pre-pregnant type 1
or 2 diabetes, inability to speak Finnish, age < 18 years,
twin pregnancy, physical restriction preventing from
physical activity, substance abuse, treatment or clinical
history of psychiatric illness.
Intervention
The trial will continue from the first maternity clinic
visit (at 8-12 weeks' gestation) until 37 weeks' gestation
(Figure 2). The recommendations for gestational weight
gain are discussed and the primary physical activity
counseling takes place at the first visit. The primary
dietary counseling session is implemented during the
visit at 16-18 weeks' gestation. Both physical activity and
dietary counseling are boost e r e da ts u b s e q u e n tv i s i t s ;
physical activity at four and diet at three visits (Figure 2).
Both physical activity and dietary counseling are based
on the model of Laitakari and Asikainen [33] which
incorporates two central behavioral models, PRECEDE-
PROCEED [34] and Stages of Change ([35]. The model
has been found applicable in occupational health care
[36] and in the pilot study on preventing excessive
gestational weight gain [27,28]. The allocated time
regarding both physical activity and dietary counseling
was 20-30 minutes for primary counseling sessions and
10-15 minutes for each of the booster sessions [27].
Counseling on gestational weight gain
The recommendations for total gestational weight gain
were 12.0-18.0 kg for women with pre-pregnancy BMI
18.5-19.9 kg/m
2, 11.5-16.0 kg for women with BMI
20.0-26.0 kg/m
2 and 7.0-11.5 kg for women with BMI ≥
26.0 kg/m
2 [37]. These recommendations were
Intervention area
Control area
Figure 1 The trial and the control municipalities in Pirkanmaa
area in south-western Finland.
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help the participant to reach her BMI-specific recom-
mendation, her rate of weight gain was monitored until
the end of pregnancy by using a BMI-specific weight
gain chart [38]. This chart was included in the partici-
pant's own follow-up notebook. Allocated time for dis-
cussion on the weight gain recommendations and
weight monitoring was 5 minutes at each of the five
visits.
Physical activity counseling
According to current American [39,40] and Canadian
guidelines [41] the general physical activity recommenda-
tion for health [42] applies to pregnant women without
medical or obstetric complications. This has been
restated in the most recent physical activity recommen-
dation updated by the Physical Activity Guidelines Advi-
sory Committee [43]. The general recommendation for
fitness [44] is also valid during pregnancy among women,
who have been regular exercisers before pregnancy and
who have uncomplicated pregnancy [40]. Borg's [45,46]
visual scale of perceived exertion (RPE) including ratings
6-20 is suggested for intensity assessment. The objectives
of the physical activity counseling were:
1) To increase leisure time physical activity (LTPA) of
those pregnant women, who are not fulfilling the
recommendations, to the recommended level for health.
2) To maintain LTPA of those pregnant women, who
are already fulfilling the recommendation for health.
3) To maintain or adjust LTPA of those pregnant
women, who are already fulfilling the recommendation
for fitness.
The structure and the topics of the physical activity
counseling sessions were guided by the counseling card,
which was filled in for each participant at each session.
At the primary session, the participant's current leisure-
time physical activity (LTPA) and her need and oppor-
tunities for LTPA were assessed and the benefits and
limitations on LTPA were discussed with the help of a
take-home leaflet. The nurse and participant agreed on
a weekly action plan including LTPA modes and their
frequency, duration and intensity, which was based on
RPE ratings 6-20 [45,46].
The minimum weekly LTPA dose entered progres-
sively in the action plan was 800 MET (multiples of
resting metabolic equivalents) minutes. Thus is in line
with Haskell et al [47] suggesting the minimum of 450
to 750 weekly MET minutes for health. Nurses calcu-
lated MET minutes from the action plans by multiplying
the weekly minutes and the MET value of each LTPA
mode and by summing up the numbers. Also light-
intensity LTPA (MET value 3) was included to the plan
due to participants' different LTPA backgrounds. RPE
6-11 equaled three METs, 12-14 five METs and 14-20
seven METs [41,44,48,49]. Compliance with the action
plan was monitored at the booster sessions with a
LTPA log, which was part of the participant's follow-up
notebook. If the action plan was revised, also the weekly
MET minutes were recalculated.
Monthly thematic meetings on physical activity
During the primary physical activity counseling visit the
participants were offered an opportunity to participate
monthly thematic meetings on physical activity includ-
ing group exercise. The sessions were arranged after the
working hours close to the maternity clinics and the
women's living area. The purpose of the meetings was
to support physical activity counseling by providing the
participants social support for behaviour change and by
introducing them various ways of being physically active.
Figure 2 Timing of the counseling in the trial clinics.
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basis, which were:
Theme 1. Physical activity is worthwhile during preg-
nancy: the benefits of physical activity, current physical
activity recommendations during pregnancy.
Theme 2. Walking is pleasant and effective: putting
technique and footwear in order.
Theme 3: More alteration and goals for walking: using
pedometers and poles.
Theme 4: Preventing urinary incontinence: pelvic
muscles and training.
Theme 5: Integrating physical activity to family life:
physical activity after pregnancy.
The dates of all the sessions were informed during the
primary counseling visit. The participants were to attend
to the next meeting after their recruitment but were
eventually able attend to every one of them during the
pregnancy. The duration of each session was two hours:
30 minutes for getting acquainted, 30 minutes for the
theoretical basis related to the theme and 1 hour for the
group exercise related to the theme. In all the sessions
RPE was used in assessing the intensity of exercise.
The sessions were instructed by the physiotherapists
of local health care centres or private clinics. A week
before each meeting a reminder of the forthcoming
meeting was transmitted via short message service from
the research institute to each participant. A week after
the meeting the instructor contacted all the participants
by telephone to encourage them to continue with their
weekly action plans and to get feedback on the meeting
from those who had attended. The instructors were
trained and provided with all the material needed for
the theoretical and practical parts of the thematic meet-
ings. Also, they were paid for the time needed for the
training, for the actual meetings and for making the tel-
ephone calls.
Dietary counseling
The aim of the dietary counseling was to help the parti-
cipants to achieve a diet containing saturated fat ≤ 10%,
polyunsaturated fat 5-10% and total fat 25-30% (includes
saturated, monounsaturated, polyunsaturated and trans
fatty acids) of total energy intake and fiber 25 to 35 g/
day. This aim was selected based on the Finnish dietary
recommendations[50], studies on the association of diet
and development of GDM [15-17] study that was suc-
cessful in preventing type 2 diabetes mellitus in Finland
[51]. To achieve this, the dietary counseling focused on
the objectives were:
1) To use vegetables, fruit and berries preferably at
least 5 portions (400 g) a day.
2) To select mostly high fiber bread (≥ 6 g fiber/100 g)
and other whole-meal products.
3) To select mostly fat-free or low-fat versions of milk
and milk products (e.g. yoghurt, cheese, ice cream) and
of meat and meat products.
4) To eat fish at least twice per week (excluding the
fish species not recommended for pregnant women).
5) To use moderate amounts of soft table spreads on
bread, oil-based salad dressing in salad and oil in cook-
ing and baking.
6) To use seldom and only in small portion sizes
foods high in fat.
7) To use seldom and only in small portion sizes
snacks containing lots of sugar and/or fat (e.g. sweets,
high-sugar drinks, cookies, ice cream, sweet and salty.
The nurse used a counseling card reminding her
about the counseling topics and to which she was able
to make remarks at each counseling session. At the pri-
mary counseling session, the nurse assessed the partici-
pant's current diet by using a check list containing the
above mentioned objectives. The nurse asked the parti-
cipant whether each of the objectives was fulfilled in her
current diet either mostly, partly or not at all. The diet-
ary recommendations were highlighted to the partici-
pants with the help of a leaflet on diet during pregnancy
(Raskausajan liikunta ja ravitsemus, MLL & Sydänliitto),
which was also given to the participant. Discussion
included participant's needs for dietary changes, as well
as her opportunities for and barriers to making the
changes. The nurse encouraged the participant to main-
tain those objectives that were already fulfilled. Of the
objectives that were not fulfilled, the participant selected
2-3 objectives which she wanted to improve in her diet.
As a consequence of this discussion, individual objec-
tives were set for the next visit (e.g. "to increase the
intake of vegetables, fruit and berries from 2 to 4 por-
tions/day" or "to decrease the intake of high-sugar
snacks from 3 to 1 portion/day"). These objectives were
written down in the follow-up note book. The partici-
pant was asked to keep weekly record whether she
achieved her objectives or not. At each booster visit, the
follow-up notebook was checked, the records were dis-
cussed and the objectives were revised if needed (e.g. set
at higher level or changed to other objectives). The
nurses also discussed about other dietary issues impor-
tant for the participants (e.g. the special dietary restric-
tions during pregnancy).
Control group
The women in the control maternity clinics received
routine care and no extra counseling beyond usual prac-
tices or group exercise were arranged. However, the
routine maternity care includes some dietary and physi-
cal activity counseling as shown in our pilot study
[27,28].
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Women who were not willing to participate in the RCT
were asked to complete the baseline questionnaire and
to give their consent for linking their information to
medical birth registry.
Outcome measurements
Outcome measurements are assessed at six times during
pregnancy (8-12, 16-18, 22-24, 26-28, 32-34, 37-39
week's gestation) and twice postpartum (6 weeks and
1 year) (Figure 3, Table 1).
The primary maternal outcome of the trial is the pro-
portion of women diagnosed with GDM, as assessed by
oral glucose tolerance test during 26-28 week's gestation
and the weight of the newborn adjusted for gestational
age.
Secondary outcomes of the trial are gestational weight
gain and need of insulin treatment during pregnancy
determined at time of possible GDM diagnosis (earliest
26-28th week of pregnancy based on OGTT). Additional
outcomes are changes in maternal physical activity (fre-
quency and duration of total and domain-specific leisure
time physical activity) and dietary habits (food choices
related to the objectives of counselling, fibre intake (g/
day) and proportions of saturated, polyunsaturated and
total fat of total energy intake), maternal quality of life
(profile of 15 health-related dimensions during preg-
nancy). Direct and indirect costs during pregnancy and
the cost-effectiveness of the trial (based on QALYs) are
calculated. Changes related to blood lipids (cholesterol,
HDL-cholesterol, triglycerides, LDL-cholesterol, oxidized
lipoproteins) and other biological markers of fat meta-
bolics (IGF, IGFBp-3, C-peptide, leptin, adiponectin,
para-oxonase) are determined both during pregnancy
and one-year postpartum.
The outcomes of the 1-year follow-up study are mainte-
nance of possible changes in physical activity and dietary
habits, incidence of metabolic syndrome based on the
International Diabetes Federation criteria [52], perceived
workability, quality of life (RAND-36 scale), depression
(Beck scale) and proportion of women returning to
work after maternity leave.
Medical birth registry linkage includes information on
perinatal outcomes (complications during pregnancy or
delivery, such as pre-eclampsia, cesarean section rate
and need for labour induction) and incidence of GDM
among non-participants.
Data collection
The timing of data collection for questionnaires, physi-
cal measurements and laboratory tests is described in
detail in Table 1.
Questionnaires
Background information on participants was collected
with the baseline questionnaire including information
from socio-economic status, smoking, earlier weight devel-
opment, use of medication and self-reported morbidity.
Physical activity habits were elicited at baseline, 36-37
weeks' gestation and 1-year postpartum. Baseline lei-
sure-time physical activity (LTPA) during a typical week
prior to the pregnancy and in the other questionnaires
LTPA during a typical week of the previous three weeks
was included. The degree of breathlessness (strong,
some, none) was used to help the women to determine
the intensity of their LTPA because there are indications
that the meaning of intensity (hard, moderate, light)
may be difficult to understand [53]. Validity and reliabil-
ity of the physical activity questions were examined in a
separate study [54].
Dietary habits were assessed by using a validated 181-
item food frequency questionnaire (FFQ) [55]. At base-
line, the women were asked questions about their diet
during one month prior to the pregnancy, since their diet
m a yh a v ec h a n g e dd u et on a u s e ao rv o m i t i n ga tt h e
beginning of the pregnancy. In the follow-up, the women
were asked questions about their diet during the previous
month. The FFQ was completed during the OGTT dur-
ing the trial and the follow-up, except for the second fol-
low-up at 36-37 weeks' gestation when the FFQ was
mailed to the participants' homes and it was returned to
the nurse at the next visit or to the researchers by mail.
Quality of life evaluation was based on the 15-D, which
is a validated instrument on quality of life [56] and visual
analogue score (VAS) for perceived health. Perceived
health has shown to be important factor in predicting
functional capacity and health [57]. The 15 D is based on
15 separate items: ability to be physically active, vision,
hearing, breathing, sleeping, eating, communicating,
elimination, normal functions, mental health, symptoms
and signs, depression, anxiety, vitality and sexuality. 15 D
scale can be used as a profile including all variables or as
a single index from zero to unity. In the 1-year follow-up
Figure 3 Design and timetable of the study: cluster-
randomized controlled trial (RCT), 1-year follow-up and linkage
to the medical birth registry.
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Beck's depression scale [59] were used.
The use of insulin therapy was included in the ques-
tionnaire at 36-37 weeks' gestation.
Workability and factors related to return to work were
elicited in the 1-year follow-up questionnaire. The work-
ability questions were adopted from workability index
developed in the Finnish Institute of Occupational
Health. The index has been shown to predict long-term
sick leave among young employees [60].
Physical measurements
Maternal anthropometric measures. Information on
maternal anthropometric measurements were obtained
from the standard maternity card. Pre-pregnancy weight
was self-reported.The nurses measured body weight of
the women at each study visit during pregnancy and
height at the first visit. Total gestational weight gain was
calculated based on the pre-pregnancy weight and last
measured weight during pregnancy. One year postpar-
tum the women were invited to local maternity clinics
or to the UKK institute for weight, waist circumference
and blood pressure measurements in order to determine
the incidence of metabolic syndrome.
Foetal anthropometric measures. Weight of the new-
born and gestational age was obtained from medical
records of the delivery hospital or from the maternity
card. Details related to delivery and perinatal complica-
tions will be received from medical birth registry.
Laboratory tests
Blood sample analyses included determination of lipids
(cholesterol, HDL-cholesterol, triglycerides, LDL-
cholesterol, oxidized lipoproteins) and other biological
markers (IGF, IGFBp-3, C-peptide, leptin, adiponectin,
para-oxonase, insulin) (Table 1). Medical laboratory
technologists from the UKK Institute or from the Cen-
tre for Laboratory Medicine in Pirkanmaa hospital dis-
trict took the blood samples (4 × 10 ml) and
performed the OGTT for all participating pregnant
women. Specimens are analyzed in analysed at Clarke-
Hilakivi's laboratory at Georgetown University,
W a s h i n g t o nD C ,U S A( I G F - 1 ,I G F B P - 3 ,e s t r a d i o l ,p r o -
gesterone, C-peptide) and in MCA research laboratory,
Turku (leptin, adiponectin, insulin, lipids) and at UKK
Institute.
OGTT. OGTT was taken at 8-12 and 26-28 weeks'
gestation and 1 year postpartum. Analyses were performed
at UKK Institute. OGTT has been shown to be the opti-
mal test for insulin sensitivity during pregnancy [61]. In
Finnish health care OGTT is performed for women at risk
of GDM 26-28 weeks' gestation, because of the expected
benefits of prevention of adverse pregnancy outcome
related to GDM. We followed the same timing and con-
veyed OGTT results to nurses who were in charge for pos-
sible further treatment. The standard OGTT was
performed by giving Glukodyn
R, including 75 g glucose in
330 ml water after overnight fasting (8 to 14 hours). The
Finnish GDM criteria were used to identify participants
with GDM [62,63]. Incremental and total area under curve
(AUC) was also calculated based on the blood glucose
values at 0, 1 and 2 hours after glucose ingestion. AUC
can be used as a measure of glucose exposure and it gives
a measure of how much and for how long glucose stays in
Table 1 Timing of questionnaires, maternal physical measurements and laboratory tests.
Weeks' gestation Postpartum
follow-up
8-12 16-18 22-24 26-28 32-34 36-37 6 weeks 1 year
Questionnaires
Background questions X
Physical activity X X X X
Food frequency X X X X
15 D quality of life X X X X X
Adverse events X X X X X
Use of insulin therapy XX
Workability X X X
Return to work X
Physical measurements
Height X
Weight X X X X X X X X
Blood pressure X X X X X X X X
Waist circumference X
Laboratory tests
Oral glucose tolerance test X X X
Blood samples X X X
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important as shorter but higher concentration. Total AUC
is a descriptive factor related to basal blood glucose value,
whereas incremental AUC more accurately describe glyce-
mic response to foods [64].
Adverse events
Adverse events related to recent physical activity were
asked by the nurses at four visits with a structured form.
The adverse events included were classified as warning
signs for exercise termination by ACOG [39], e.g. vaginal
bleeding, major contractions, dizziness, headache, chest
pain and muscle weakness.
Cost-effectiveness
Total costs of the trial are calculated by summing up
all direct costs and dividing the sum by the number of
participants. Cost-effectiveness analysis includes differ-
ences in direct and indirect costs between the trial and
the control groups. Direct costs include all consulta-
tions within the health care sector both in specialized
and non-specialized care during the trial period (from
baseline examinations until delivery). Hospital days,
medications and laboratory cost are also included.
Costs for the pregnant women include medications
and travelling. Trial costs include trial materials, train-
ing the nurses for the counseling and the time used
for implementation of the counselling and data collec-
tion at the routine maternity care visits. Indirect costs,
like productivity loss includes absenteeism from work
based on the number of days on sick leave during
pregnancy. The evaluation of health outcomes is based
on quality adjusted life years (QALY). The QALY is
based on the number of years of life that would be
added by the trial[65].
Process evaluation
The data collected for the process evaluation include e.g.
the number of participating women in each clinic, parti-
cipation rate among all invited women, drop out rate,
number of returned questionnaires in the study and par-
ticipation rate in the monthly thematic meetings on
physical activity. Information on reasons for non-partici-
pation was enquired from those women who refused to
participate.
Information on the feasibility of the counseling was
collected by structured telephone interviews to the
nurses of the trial clinics after the trial. The interview
included questions on perceived pros and cons related
to the contents and procedure of counseling and data
collection as well as the nurse's willingness to utilize the
approach in their work. The questions were tested in
the pilot study and modified for this purpose.
Power calculations and sample size
The randomization of maternity clinics as clusters
instead of women as individuals was taken into account
in the power calculations [66]. When planning the RCT,
no published studies on prevention of GDM among
women at risk or data on decrease in the incidence of
GDM were available. The power calculations for pair-
matched study were based on the assumption of detect-
ing a 40% reduction of incidence of GDM from 40% in
the control clinics to 24% in the trial clinics. The power
of the study was 0.80, significance level 0.05 and coeffi-
cient of variation of rate between clusters, indicating
cluster sampling, 0.1. The dropout rate during the study
(estimated 25%) was taken into account in the sample
size calculations. Thus, a total number of 560 women
should be recruited to the study. The number of women
in the end of the study would thus be 210 + 210 (7+7
clinics, 30 women/clinic).
Success in recruitment and proportion of drop-outs
(25%) were estimated based on the pilot study [28,67].
Our recruitment target seemed feasible since the annual
number of deliveries in Pirkanmaa region was approxi-
mately 5000 [31] and at least fourth of these women
were estimated to fulfill the inclusion criteria of this
study.
The sample available for the 1-year follow-up
(n = 462) is adequate to discover 5-20% difference of
metabolic syndrome in trial and control groups.
Intracluster correlation coefficient in the current study
is estimated as 0.12 (valid when 0.10-0.30) [68].
Statistical analysis
The main method in the comparison of the trial and the
control group is the multilevel analysis. In the multilevel
analysis, both individual-level, nurse-level and clinic-level
influences on the outcomes can be examined simulta-
neously and the results are corrected for between-clinic
and between-nurse variation. Also non-parametric meth-
ods will be utilized when applicable. The choice of
method depends on the measurement scale and distribu-
tion of the outcome variable. Intention-to-treat principle
is followed, i.e. the analysis is performed in originally ran-
domized groups. Information on drop-outs is received
through linkage to birth registry. Intention-to-treat ana-
lyses are performed after birth registry linkage. A second-
ary analysis is performed without the drop-outs.
Discussion
The trial is expected to be effective in short-term pre-
vention of gestational diabetes. The possible long-term
benefits include prevention of chronic diseases, such as
type 2 diabetes and cardiovascular diseases, both in
mother and offspring.
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Page 8 of 11The design of the study was a cluster-randomized trial
instead of individual randomization. Contamination of
nurses counseling practices would have been larger if
individuals had been randomized instead of maternity
clinic areas. Even though cluster randomization requires
larger sample size, the results may be more easily
applied to health care. Our purpose was not to build a
design with maximal support for lifestyle modification,
because it would not have been applicable in real health
care setting. Embedding the trial into ongoing maternal
care we aimed to increase the effectiveness rather than
efficacy of the intervention.
Finland is one of the countries with nationally cover-
ing maternity center network funded by public taxation.
If our trial was proved to be a cost-effective way to pre-
vent gestational and perinatal complications it might be
applicable and might have large public health impact
even in those countries with different maternity care
systems.
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